Table I.
N | EMCI | LMCI | AD | |
---|---|---|---|---|
Sample Size (n) | 194 | 212 | 132 | 64 |
Age (mean/sd) | 77.0(6.1) | 71.3(7.5) | 75.8(7.9) | 75.8(8.4) |
Age range (yrs) | 64–94 | 55–89 | 55–92 | 56–90 |
Education years (mean/sd) | 16.3(2.8) | 15.9(2.6) | 16.1(2.8) | 16.2(2.8) |
PET Global SUVR (means/sd) | 1.10(0.2) | 1.15(0.2) | 1.23(0.2) | 1.34(0.3) |
PET Cingulate SUVR (means/sd) | 1.18(0.2) | 1.25(0.2) | 1.32(0.3) | 1.43(0.3) |
PET Frontal SUVR (means/sd) | 1.08(0.2) | 1.15(0.2) | 1.23(0.2) | 1.35(0.3) |
PET Parietal SUVR (means/sd) | 1.10(0.2) | 1.15(0.2) | 1.23(0.2) | 1.35(0.3) |
PET Temporal SUVR (means/sd) | 1.03(0.2) | 1.07(0.2) | 1.15(0.2) | 1.25(0.2) |
Gender ratio (M/F) | 1.00 | 1.30 | 1.59 | 1.56 |
APOE ε4 status (ε4−/ε4+)* | 146/44 | 121/83 | 71/58 | 22/41 |
APOE data missing for 16 subjects (4 N, 8 EMCI, 3 MCI, 1 AD); they were omitted from genetic analysis.